Phicrobe
West Lafayette, US · 1 known investors
Find your way into Phicrobe
Sign up to find every way you can get introduced to Phicrobe
- Your email: who you already know at Phicrobe, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Phicrobe team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Phicrobe develops rapid diagnostic tests for detecting E. coli O157:H7 using genetically modified bacteriophage technology that produces light in the presence of the pathogen. The technology enables pathogen detection without specialized equipment or expensive reagents for use in food safety and clinical testing applications.
Investors · 1
Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Phicrobe do?
- Phicrobe develops rapid diagnostic tests for detecting E. coli O157:H7 using genetically modified bacteriophage technology that produces light in the presence of the pathogen. The technology enables pathogen detection without specialized equipment or expensive reagents for use in food safety and clinical testing applications.
- Who are Phicrobe's investors?
- Phicrobe's investors include Elevate Ventures.
- Where is Phicrobe headquartered?
- Phicrobe is headquartered in West Lafayette, US.